Exozymes EXOZ
NASDAQ EXOZ
$7.04 +0.64 (+10.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Exozymes (EXOZ) Current Leases (2023 - 2026)

Exozymes (EXOZ) posted quarterly Current Leases of $44255.0 for Q4 2025, down 80.76% year-over-year from $230027.0 in Q4 2024, and up 3.83% quarter-over-quarter from $42623.0 in Q3 2025.

Exozymes (EXOZ) Current Leases (2023 - 2026) Analysis & Trends

Exozymes (EXOZ) has reported Current Leases for 3 consecutive years, with $44255.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Leases fell 80.76% year-over-year to $44255.0; the TTM figure through Dec 2025 stood at $44255.0 (down 80.76% YoY), while the FY2025 annual figure was $44255.0, down 80.76% from the prior year.
  • Current Leases grew to $44255.0 in Q4 2025 per EXOZ's latest filing, from $42623.0 in the prior quarter.
  • Across five years, Current Leases topped out at $243691.0 in Q2 2025 and bottomed at $42623.0 in Q3 2025.
  • Historically, Current Leases has averaged $178020.0 across 3 years, with a median of $224988.0 in 2023.
  • Annual changes were most pronounced in 2024 — Current Leases rose 2.24% — and 2025, when it slumped 80.95%.
  • Exozymes' Current Leases stood at $224988.0 in 2023, then rose by 2.24% to $230027.0 in 2024, then tumbled by 80.76% to $44255.0 in 2025.
  • Business Quant data shows EXOZ's Current Leases at $44255.0 in Q4 2025, $42623.0 in Q3 2025, and $243691.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 21.95 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 45.93 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 6.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Exozymes 61.53 Mn 61.53 Mn - 297,778.00

Historic Data

Download Data
DateValue
Jun 30, 2026 297,778.00
Dec 31, 2025 44,255.00
Sep 30, 2025 42,623.00
Jun 30, 2025 243,691.00
Mar 31, 2025 236,795.00
Dec 31, 2024 230,027.00
Sep 30, 2024 223,761.00
Dec 31, 2023 224,988.00